Finzati - Logo
IRMD logo

IRadimed Corporation

IRMD • Medical - Devices
$83.45
▼ -3.14 (-3.63%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.07B
Growth
18.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 26.8%Positive revenue growth · 18.1%Positive free cash flow · 1.35Consistent free cash flow · 5/5Manageable debt level · 0
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$83.45
Change-3.63%
Shares Out12.87M
Market Cap$1.07B
Enterprise Value$1.02B
52W Range66.78 - 107.90
Beta0.91
P/E46.59
P/S12.44
P/B10.56
P/FCF42.98
EV/Sales11.76

Investment DNA

How strong this company looks for long-term investors

75
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Stable or improving margins · 26.8%Positive revenue growth · 18.1%Positive free cash flow · 1.35Consistent free cash flow · 5/5Manageable debt level · 0Healthy liquidity · 7.98

Analyst view

Analyst sentiment and price target

IRMD
Analyst sentiment
Based on 2 analyst votes · 2026-09-04
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-02
Low
$120.00
Mean
$120.00
Median
$120.00
High
$120.00

Company Overview

IPO: 7/16/2014
Industry: Medical - Devices
P/B i: 10.56
Debt / Equity i: 0.00
Operating Margin: 31.20%
Net Margin: 26.82%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 7.98
Quick Ratio: 6.84
Status: Good

Insider Transactions

Recent executive and insider activity

GLENN JOHN
Transaction: 06/20/2026
SELL
Change
-5,796
Price
Not reported
Filing
06/23/2026
Type
SELL
GLENN JOHN
Transaction: 06/20/2026
SELL
Change
-2,319
Price
$92.20
Filing
06/23/2026
Type
SELL
Scharen-Guivel Hilda Frederique
Transaction: 06/04/2026
SELL
Change
-1,234
Price
$95.00
Filing
06/04/2026
Type
SELL